|
- Systematic coverage of advances in cardiometabolic risk research
- Compares emergent and classical cardiometabolic risk biomarkers
- Discusses clinical relevance of cardiometabolic risk
This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders. Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors, and clinical and basic researchers working on cardiovascular and autoimmune disorders. Table of Contents- Inflammation biomarkers and cardiometabolic risk
- Cardiovascular disease
- Diabetes mellitus and metabolic syndrome
- Ischemic stroke
- Chronic kidney disease
- Immune-mediated inflammatory rheumatic diseases
- Cardiometabolic risk, inflammation and neurodegenerative disorders
|
